China fast tracks IPO by leading biotech firm WuXi AppTec, in race as Asia’s hub for fundraising

WuXi AppTec, the mainland’s leading biotechnology firm which privatised in New York two years ago, has been given the green light to relist on the A-share market via an initial public offering (IPO) in Shanghai, just seven weeks after filing its application.
( read original story …)